Last reviewed · How we verify
Treatment of moderate to severe vasomotor symptoms associated with the menopause
Approved treatments
- Menest · Pfizer Inc.
Esterified estrogens, sold under the brand names Estratab and Menest, are used for hormone therapy and cancer treatment.
Clinical guidelines
- FDA label — 1L
Estrogens, esterified (Menest) is indicated for the treatment of female hypogonadism. - FDA label — 1L
Estrogens, esterified (Menest) is indicated for the treatment of female castration. - FDA label — 1L
Estrogens, esterified (Menest) is indicated for the treatment of primary ovarian failure. - FDA label — 2L
Estrogens, esterified (Menest) is indicated for the palliation of breast cancer in appropriately selected women and men with metastatic disease. - FDA label — 2L
Estrogens, esterified (Menest) is indicated for the palliative therapy of advanced prostatic carcinoma. - FDA label — 1L
Estrogens, esterified (Menest) is indicated for the treatment of moderate to severe vasomotor symptoms associated with the menopause. - FDA label — 1L
Estrogens, esterified (Menest) is indicated for the treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause. Topical vaginal products should be considered when prescribing solely for these symptoms.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Treatment of moderate to severe vasomotor symptoms associated with the menopause patent landscape — cliff calendar, originator estates, attackable patents
- Treatment of moderate to severe vasomotor symptoms associated with the menopause treatment landscape brief
- Treatment of moderate to severe vasomotor symptoms associated with the menopause treatment updates RSS
Frequently asked questions about Treatment of moderate to severe vasomotor symptoms associated with the menopause
What drugs treat Treatment of moderate to severe vasomotor symptoms associated with the menopause?
Tracked treatments include Menest.
What is the treatment for Treatment of moderate to severe vasomotor symptoms associated with the menopause?
Standard treatment for Treatment of moderate to severe vasomotor symptoms associated with the menopause includes Menest. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Treatment of moderate to severe vasomotor symptoms associated with the menopause?
FDA label publishes guidelines for Treatment of moderate to severe vasomotor symptoms associated with the menopause. 7 guideline references tracked.
Related
- Treatment landscape: Treatment of moderate to severe vasomotor symptoms associated with the menopause patent cliff · Treatment of moderate to severe vasomotor symptoms associated with the menopause CI report
- Treatment: Menest · Pfizer Inc.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing